Amrize’s (AMRZ) “Hold (C)” Rating Reaffirmed at Weiss Ratings

Weiss Ratings reissued their hold (c) rating on shares of Amrize (NYSE:AMRZFree Report) in a research note released on Thursday morning,Weiss Ratings reports.

AMRZ has been the topic of a number of other research reports. UBS Group increased their price target on shares of Amrize from $49.00 to $52.00 and gave the company a “neutral” rating in a report on Tuesday, October 14th. Kepler Capital Markets upgraded shares of Amrize to a “strong-buy” rating in a report on Tuesday, October 21st. Zacks Research upgraded shares of Amrize from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Wells Fargo & Company raised their target price on shares of Amrize from $57.00 to $58.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, Wall Street Zen upgraded shares of Amrize to a “hold” rating in a report on Saturday, October 25th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, Amrize presently has an average rating of “Moderate Buy” and a consensus target price of $58.14.

View Our Latest Report on Amrize

Amrize Stock Down 1.8%

NYSE:AMRZ opened at $51.90 on Thursday. The firm’s 50 day moving average price is $50.60. Amrize has a 52 week low of $44.12 and a 52 week high of $56.29. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $28.71 billion and a PE ratio of 66.54.

Amrize (NYSE:AMRZGet Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.25). The firm had revenue of $3.22 billion for the quarter.

Insider Buying and Selling at Amrize

In other Amrize news, insider Jaime Hill purchased 4,000 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were acquired at an average price of $46.40 per share, for a total transaction of $185,600.00. Following the purchase, the insider directly owned 9,601 shares of the company’s stock, valued at $445,486.40. The trade was a 71.42% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Stephen S. Clark purchased 5,000 shares of the company’s stock in a transaction dated Friday, August 15th. The shares were acquired at an average price of $51.82 per share, for a total transaction of $259,100.00. Following the purchase, the insider directly owned 5,000 shares in the company, valued at approximately $259,100. The trade was a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders have bought 1,124,000 shares of company stock worth $53,225,260.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of AMRZ. Global Retirement Partners LLC purchased a new position in shares of Amrize during the 3rd quarter worth $48,000. BNP Paribas Financial Markets purchased a new position in shares of Amrize during the 2nd quarter worth $59,000. Groupe la Francaise purchased a new position in shares of Amrize during the 2nd quarter worth $60,000. Allianz SE purchased a new position in shares of Amrize during the 2nd quarter worth $80,000. Finally, Osaic Holdings Inc. purchased a new position in shares of Amrize during the 2nd quarter worth $90,000.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.